Indiaโ€™s Bio-Economy Set to Hit $1 Trillion by 2047, Says Minister

Union Minister Dr. Jitendra Singh announced that India's bio-economy is projected to grow to $1 trillion by 2047, making it one of the top three global bio-economies. He highlighted that the sector has expanded from $10 billion in 2014 to over $165 billion today, growing at nearly 18% annually. The number of biotech startups has surged from around 50 to more than 11,000, reflecting a robust innovation ecosystem. The minister also noted India's improved Global Innovation Index ranking and significant scientific advances in areas like genome research, CAR-T cell therapy, and mRNA vaccine platforms.

Key Points: India's Bio-Economy Projected to Reach $1 Trillion by 2047

  • Bio-economy to reach $1 trillion by 2047
  • Grew from $10 billion (2014) to $165 billion now
  • Biotech startups jumped from 50 to over 11,000
  • India's Global Innovation Index ranking improved from 81 to 39
2 min read

India's bio-economy projected to touch $1 trillion by 2047: Minister

Union Minister Dr. Jitendra Singh says India's bio-economy will hit $1 trillion by 2047, with biotech startups surging from 50 to 11,000.

"The twenty-first century will be 'India's century' driven by a biology-led economy. - Dr. Jitendra Singh"

New Delhi, April 24

Union Minister Dr Jitendra Singh on Friday said that India's bio-economy is projected to grow to $1 trillion by 2047, emerging as one of the top three global bio-economies.

The twenty-first century will be "India's century" driven by a biology-led economy, the minister told an international conference at IIT Roorkee.

India is advancing towards full-spectrum technological capability "from gene to qubit, from ocean depths to outer space," supported by policy reforms, strong institutional frameworks and a rapidly expanding innovation ecosystem, an official statement cited the minister as saying.

Referring to developments in emerging technologies, he said the National Quantum Mission has achieved key milestones ahead of schedule, while India has entered the top ranks globally in several critical technology domains. He noted that India's Global Innovation Index ranking has improved from 81 to 39, and that research and development expenditure has more than doubled over the past decade, reflecting sustained national prioritisation of science and innovation.

India's bio-economy has expanded from $10 billion in 2014 to over $165 billion today, growing at nearly 18 per cent annually, with a target of $300 billion by 2030, he said.

The number of biotech startups jumped from around 50 to more than 11,000, the statement from the Ministry of Science & Technology said.

He also referred to the Anusandhan National Research Foundation (ANRF) with a Rs 50,000 crore corpus and the Rs 1 lakh crore Research, Development and Innovation (RDI) Fund, designed to provide long-term, low-cost financing for deep-tech innovation.

Dr. Jitendra Singh presented a series of major scientific advances achieved in recent years, including progress under Genome India, indigenous CAR-T cell therapy, development of mRNA vaccine platforms, India's first indigenously developed antibiotic, etc.

He also highlighted the expansion of nuclear medicine facilities to deliver affordable cancer care and progress in deep ocean exploration through missions such as Samudrayaan.

- IANS

Share this article:

Reader Comments

P
Priya Sharma
Finally, something to be proud of! From $10 billion to $165 billion in a decade is impressive growth. But the target of $300 billion by 2030 seems too ambitious given global economic slowdown. Let's see how much actually trickles down to our tier-2 cities. ๐Ÿงช๐Ÿ”ฌ
M
Michael Chen
As someone working in biotech in Bangalore, I can confirm this is real. The startup ecosystem here is exploding! From just 50 biotech startups to 11,000 is mind-blowing. The ANRF corpus of Rs 50,000 crore is a game-changer for deep tech innovation. India's bio-revolution is happening.
R
Rajesh Kumar
Impressive numbers but where is the ground reality? I'm a biotech researcher in a government university and we still struggle for basic funding and equipment. High time we bridge the gap between policy papers and labs. The CAR-T cell therapy sounds great but its cost needs to be affordable for common man. ๐Ÿงฌ
S
Sarah Johnson
As an NRI, I love seeing India lead in bio-economy. The Genome India project and indigenous antibiotic development are huge achievements. But I worry about brain drain โ€” many of my colleagues in US/UK are Indian scientists. We need better incentives to retain talent back home. ๐Ÿ‡ฎ๐Ÿ‡ณ
V
Vikram Desai
From gene to qubit, ocean to space โ€” the vision is ambitious but execution will be key. Happy to see India entering top ranks in critical technologies. Just hope the 18% annual growth sustains and benefits all states equally, not just Maharashtra, Karnataka, and Telangana. Samudrayaan sounds fascinating! ๐ŸŒŠ๐Ÿš€

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50